Candidiasis
📧 Sign up to get email alerts when something new happens for Candidiasis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-22EMA Authorised: Voriconazole Accord (voriconazole) — Accord Healthcare S.L.U.
The EMA authorised Voriconazole Accord (voriconazole) for treatment of fungal infections including Aspergillosis, Candidiasis, and Mycoses, …
-
EMA approval · 2026-07-21EMA Authorised: Vfend (voriconazole) — Pfizer Europe MA EEIG
Pfizer's voriconazole (Vfend) has been authorised by EMA for use in fungal infections including candidiasis, mycoses, and aspergillosis.
-
EMA approval · 2026-07-01EMA Authorised: Noxafil (posaconazole) — Merck Sharp and Dohme B.V
EMA authorises Noxafil (posaconazole) for multiple fungal infections including candidiasis, mycoses, coccidioidomycosis, and aspergillosis.
-
EMA approval · 2026-06-15EMA Authorised: Rezzayo (rezafungin) — Mundipharma GmbH
EMA authorised Rezzayo (rezafungin) for candidiasis and invasive candidiasis, marketed by Mundipharma GmbH.
-
EMA approval · 2026-06-12EMA Authorised: Posaconazole Accord (posaconazole) — Accord Healthcare S.L.U.
Authorised status for Posaconazole Accord, MAH Accord Healthcare S.L.U., in the therapeutic area of mycoses.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2026-04-28EMA Authorised: Vfend (voriconazole) — Pfizer Europe MA EEIG
European Medicines Agency authorises Vfend (voriconazole) for fungal infections including candidiasis, mycoses, and aspergillosis.
-
EMA approval · 2026-04-22EMA Authorised: Noxafil (posaconazole) — Merck Sharp and Dohme B.V
The EMA has granted marketing authorization for Noxafil (posaconazole) by Merck Sharp & Dohme B.V. for the treatment and prevention of funga…
-
EMA approval · 2026-04-14EMA Authorised: Vfend (voriconazole) — Pfizer Europe MA EEIG
The European Medicines Agency authorised Vfend (voriconazole) for fungal infections including candidiasis and aspergillosis.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Prospective Clinical Study, Using a Medical Device (RepHegyn) as an Adjuvant in the Treatment of Fungal (Candidiasis) and Bacterial Infections
Prospective clinical study evaluating the medical device RepHegyn as an adjuvant in the treatment of candidiasis and bacterial infections; t…
-
EMA approval · 2026-04-08EMA Authorised: Rezzayo (rezafungin) — Mundipharma GmbH
The European Medicines Agency authorized Rezzayo (rezafungin) from Mundipharma GmbH for the treatment of candidiasis, including invasive can…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Rezafungin Peritoneal Diffusion for Intra-abdominal Candidiasis
Clinical trial update for rezafungin evaluating peritoneal diffusion to treat intra-abdominal candidiasis; recruiting at a French center.
-
FDA approval · 2026-01-14FDA Approved: FLUCONAZOLE IN SODIUM CHLORIDE — Supplemental Application (Hospira, Inc.)
The FDA approved Hospira's supplemental application for Fluconazole in Sodium Chloride (intravenous formulation), adding this generic IV flu…
-
EMA approval · 2026-01-08EMA Authorised: Cancidas (previously Caspofungin MSD) (caspofungin (as acetate))
EMA has authorised Cancidas (caspofungin acetate) for the treatment of candidiasis and aspergillosis.
-
EMA approval · 2026-01-06EMA Authorised: Voriconazole Hikma (previously Voriconazole Hospira) (voriconazole) — Hikma Farmaceutica (Portugal) S.A.
The EMA authorised Voriconazole Hikma for fungal infections, including aspergillosis and candidiasis, with Hikma Farmaceutica (Portugal) S.A…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: PTX3-targeted Antifungal Prophylaxis [NA]
A clinical trial is recruiting to evaluate PTX3-targeted antifungal prophylaxis for preventing candidiasis and other fungal infections, incl…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Biofilm Formation and Antifungal Resistance in Candida Species
A clinical trial from Assiut University is studying biofilm formation and antifungal resistance in Candida species, for candidiasis, and is …
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Staging Candidiasis in ICU Patients
This clinical trial update notes that a study on staging candidiasis in ICU patients has completed. The sponsor listed is Centre Hospitalier…
-
FDA approval · 2025-11-14FDA Approved: VORICONAZOLE — Original Application (Hainan Poly Pharm. Co., Ltd.)
The FDA approved a generic Voriconazole product from Hainan Poly Pharm. Co., Ltd. via an Original Application (ANDA 220043). It covers voric…
-
EMA approval · 2025-10-21EMA Authorised: Voriconazole Accord (voriconazole) — Accord Healthcare S.L.U.
The European Medicines Agency authorised Voriconazole Accord (voriconazole) for treating aspergillosis, candidiasis and other mycoses; the m…
-
EMA approval · 2025-10-13EMA Authorised: Mycamine (micafungin) — Sandoz Pharmaceuticals d.d.
The EMA authorised Mycamine (micafungin) for candidiasis, with Sandoz Pharmaceuticals d.d. as the marketing authorization holder.
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Kinetics of Serum β-D-glucan During Peritonitis With Candida in Resuscitation [NA]
A completed clinical trial examining the kinetics of serum β-D-glucan during resuscitation in patients with Candida-associated peritonitis.
-
EMA approval · 2025-09-09EMA Authorised: Ecalta (anidulafungin) — Pfizer Europe MA EEIG
The European Medicines Agency authorised Ecalta (anidulafungin) for the treatment of candidiasis. Pfizer Europe MA EEIG is the marketing aut…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Fluconazole Versus Micafungin in Neonates With Candidiasis [Phase 2, Phase 3]
The clinical trial comparing fluconazole versus micafungin in neonates with candidiasis has completed Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Pharmacokinetic Study in Healthy Lactating Women Exposed to Ibrexafungerp [Phase 1]
Phase 1 pharmacokinetic study of ibrexafungerp in healthy lactating women completed; results were posted on 2025-08-08.
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Diagnostic Performance of the CandID PLUS PCR for the Diagnosis of Intra-abdominal Candidiasis in Critically Ill Patients
This completed clinical trial assesses the diagnostic performance of the CandID PLUS PCR assay for intra-abdominal candidiasis in critically…